MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Mechanistic Insights of Tamarindus indica in Acrylonitrile-Induced Neurodegeneration

    L. Usman, E. Ajani, A. Akinmoladun, R. Ibrahim, R. Aladodo (Ilorin, Nigeria)

    Objective: The study provides an understanding of the nature of the bioactive compounds of Tamarindus indica fruit pulp and their therapeutic potential using in vitro, in…
  • 2025 International Congress

    Dietary Caffeic Acid Exhibits Neuroprotective and Neuromodulatory Effects in a Parkinsonian Rat Model by Mitigating Oxidative Stress, Mitochondrial Dysfunction, and Apoptosis

    A. Singh (Prayagraj, India)

    Objective: This study investigated the neuroprotective and neuromodulatory effects of dietary caffeic acid (CA) in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinsonian rat model Background: Parkinson’s disease (PD)…
  • 2025 International Congress

    Findings of motoric and neuro psychological outcome using high frequency stimulations in Parkinsons with STN-DBS

    A. Dabbeta, V. Rama Raju (Hyderabad, India)

    Objective: For testing the likelihood of decreasing psychiatric dyskinesias of STN-DBS, conducting experimentally and through experimental studies we explore the properties of in what best…
  • 2025 International Congress

    Traumatic DBS Implant exposure following head injury and its management – a case report.

    A. Uppar (BANGALORE, India)

    Objective: To present management plan employed in treatment of a case of traumatic exposure of lead wires in a known case of Idiopathic  Parkinson’s disease(PD)…
  • 2025 International Congress

    Anterior Pallidal Stimulation for Severe Tourette Syndrome: Open Phase Outcomes

    P. Limousin, T. Foltynie, V. Lind, M. Krueger, H. Akram, J. Esperida, C. Milabo, H. Tyagi, D. Bindman, M. Silverdale, G. Auld, H. Sims, K. Chowdhury, N. Ahmed, A. King, L. Zrinzo, E. Joyce (London, United Kingdom)

    Objective: To present the open phase outcomes of a trial of anterior pallidal stimulation (antGPi DBS) on tic severity in patients with severe Tourette syndrome…
  • 2025 International Congress

    Mitigating Risk and Expanding Movement Disorder Specialist Capacity: Advancing Parkinson’s Disease Management with Integrated Monitoring, Targeted Triage and Improved Patient-Clinician Communication in Parkinson’s Disease.

    A. Arnold, T. Jansen, A. Hare, S. Shaffer, S. Khandhar, R. Gilron (San Francsico, USA)

    Objective: Empower patients with exercise-focused motivational frameworks and personalized tracking for real-time health insights, while reducing clinician burden through continuous monitoring and targeted health coaching—all…
  • 2025 International Congress

    Investigating the Neuroprotective Potential of Mushroom Extracts in Parkinson’s Disease In Vitro Models

    SEO. Seo, FAZ. Dustov (Tashkent, Uzbekistan)

    Objective: This study aims to evaluate the neuroprotective potential of various mushroom extracts in in vitro models of PD. Background: Parkinson’s disease (PD) is a…
  • 2025 International Congress

    Computer Vision Quantification of Repeated Finger Tapping Demonstrates Aberrant Plasticity in Parkinson’s Disease

    D. Newbold, U. Kang (New York, USA)

    Objective: Test if symptoms of Parkinson's disease (PD) develop through aberrant plasticity. Background: Recent results in 6-hydroxydopamine-lesioned mice show that repeated performance of simple motor…
  • 2025 International Congress

    Assessment of the impact of the diabetic features hyperglycemia and insulin resistance on fibril induced synucleinopathy

    S. Nelson, G. Barajas, A. Cole-Strauss, M. Kubik, C. Kemp, C. Sortwell, J. Patterson (Grand Rapids, USA)

    Objective: Investigate the effects of diabetic features on the induction and severity of synucleinopathies such as Parkinson’s disease (PD). Background: Type 2 diabetes (T2D) is…
  • 2025 International Congress

    Subdomain-specific cognitive decline and its effect on caregiver burden in Mexican population living with Parkinson’s Disease.

    G. Martin-Mafud, A. Hernández-Medrano, E. Ramírez-Benitez, A. Cervantes-Arriaga, M. Rodríguez-Violante, D. Ulloa-Hernández, M. Velasco-Delgado (Mexico City, Mexico)

    Objective: To determine whether different subdomains of the MoCA associate with caregiver burden. Background: Caregivers improve the quality of life for Parkinson's patients (PwP), despite…
  • « Previous Page
  • 1
  • …
  • 148
  • 149
  • 150
  • 151
  • 152
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Life expectancy with and without Parkinson’s disease in the general population
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley